JP2022535064A5 - - Google Patents
Info
- Publication number
- JP2022535064A5 JP2022535064A5 JP2021571699A JP2021571699A JP2022535064A5 JP 2022535064 A5 JP2022535064 A5 JP 2022535064A5 JP 2021571699 A JP2021571699 A JP 2021571699A JP 2021571699 A JP2021571699 A JP 2021571699A JP 2022535064 A5 JP2022535064 A5 JP 2022535064A5
- Authority
- JP
- Japan
- Prior art keywords
- polysaccharide
- protein conjugate
- streptococcus pneumoniae
- serotypes
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962857534P | 2019-06-05 | 2019-06-05 | |
| US62/857,534 | 2019-06-05 | ||
| PCT/US2020/035511 WO2020247301A1 (en) | 2019-06-05 | 2020-06-01 | Methods of treating patients with an immunogenic composition that protects against s. pneumoniae serotype 29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022535064A JP2022535064A (ja) | 2022-08-04 |
| JP2022535064A5 true JP2022535064A5 (cg-RX-API-DMAC7.html) | 2023-06-20 |
Family
ID=73653320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571699A Pending JP2022535064A (ja) | 2019-06-05 | 2020-06-01 | 肺炎レンサ球菌血清型29から保護する免疫原性組成物で患者を治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220218812A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3980050A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022535064A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220016964A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114025784A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020289048A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021024491A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3142697A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021014948A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020247301A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018144439A1 (en) | 2017-01-31 | 2018-08-09 | Merck Sharp & Dohme Corp. | Methods for making polysaccharide-protein conjugates |
| JP7680185B2 (ja) | 2017-02-24 | 2025-05-20 | メルク・シャープ・アンド・ドーム・エルエルシー | 肺炎連鎖球菌多糖-タンパク質コンジュゲートの免疫原性の増強 |
| US11395849B2 (en) | 2017-09-07 | 2022-07-26 | Merck Sharp & Dohme Llc | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| CN111065387B (zh) | 2017-09-07 | 2023-08-25 | 默沙东有限责任公司 | 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途 |
| EP3720483B1 (en) | 2017-12-06 | 2025-11-19 | Merck Sharp & Dohme LLC | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| WO2019212846A1 (en) | 2018-04-30 | 2019-11-07 | Merck Sharp & Dohme Corp. | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates |
| JP7397000B2 (ja) | 2018-04-30 | 2023-12-12 | メルク・シャープ・アンド・ドーム・エルエルシー | 凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法 |
| WO2019212842A1 (en) | 2018-04-30 | 2019-11-07 | Merck Sharp & Dohme Corp. | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres |
| EP3897705A2 (en) | 2018-12-19 | 2021-10-27 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2311976A1 (en) * | 2009-10-19 | 2011-04-20 | Azienda Ospedaliero-Universitaria Meyer | Method for Streptococcus Pneumoniae diagnosis and serotyping |
| TW201136603A (en) * | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| US11058757B2 (en) * | 2016-03-31 | 2021-07-13 | Pogona, LLC | Saccharide-polypeptide conjugate compositions and methods of use thereof |
| CN109789198B (zh) * | 2016-09-30 | 2024-08-16 | 生物E有限公司 | 包含多糖-蛋白缀合物的多价肺炎球菌疫苗组合物 |
| IL267709B2 (en) * | 2016-12-30 | 2025-04-01 | Vaxcyte Inc | Polypeptide-antigen conjugates with unnatural amino acids |
-
2020
- 2020-06-01 MX MX2021014948A patent/MX2021014948A/es unknown
- 2020-06-01 AU AU2020289048A patent/AU2020289048A1/en not_active Abandoned
- 2020-06-01 JP JP2021571699A patent/JP2022535064A/ja active Pending
- 2020-06-01 US US17/614,876 patent/US20220218812A1/en not_active Abandoned
- 2020-06-01 EP EP20819293.0A patent/EP3980050A4/en not_active Withdrawn
- 2020-06-01 WO PCT/US2020/035511 patent/WO2020247301A1/en not_active Ceased
- 2020-06-01 KR KR1020227000140A patent/KR20220016964A/ko not_active Withdrawn
- 2020-06-01 CA CA3142697A patent/CA3142697A1/en active Pending
- 2020-06-01 BR BR112021024491A patent/BR112021024491A8/pt unknown
- 2020-06-01 CN CN202080049226.4A patent/CN114025784A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3720483T3 (fi) | Streptococcus pneumoniaen polysakkaridi-proteiinikonjugaatteja käsittäviä koostumuksia ja niiden käyttömenetelmiä | |
| PH12022550110A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same | |
| JP2019526621A5 (cg-RX-API-DMAC7.html) | ||
| IL276229B2 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| JP2021505589A5 (cg-RX-API-DMAC7.html) | ||
| PH12020551149A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| JP2021512870A5 (cg-RX-API-DMAC7.html) | ||
| PH12019500240A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| JP2022542316A5 (cg-RX-API-DMAC7.html) | ||
| JP2019526620A5 (cg-RX-API-DMAC7.html) | ||
| NZ755770A (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| PE20211888A1 (es) | Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y sus metodos de uso | |
| SA519401028B1 (ar) | تركيب متقارن من عديد السكاريد للمكورة الرئوية متعددة التكافؤ - وبروتين | |
| JP2022513562A5 (cg-RX-API-DMAC7.html) | ||
| HRP20221438T1 (hr) | Postupak glikokonjugiranja | |
| HRP20161681T1 (hr) | Cjepivo protiv bakterije streptococcus pneumoniae | |
| BR112021024491A2 (pt) | Composição imunogênica, e, método para prevenir, tratar ou melhorar uma infecção, doença ou condição | |
| JP2024103612A5 (cg-RX-API-DMAC7.html) | ||
| RU2021138121A (ru) | Способы лечения пациентов иммуногенной композицией, защищающей от серотипа 29 s. pneumoniae | |
| EA202091440A1 (ru) | Поливалентная противопневмококковая полисахаридно-белковая конъюгированная композиция | |
| AR122291A1 (es) | Composiciones conjugadas neumocócicas multivalentes polisacárido - proteína y métodos para usar las mismas | |
| Choi et al. | Serotypes and antimicrobial susceptibility of Streptococcus pneumoniae | |
| Melo-Cristino et al. | 774; Non-invasive pneumococcal pneumonia has its own and distinct serotype distribution in Portugal | |
| RU2020133440A (ru) | КАПСУЛЬНЫЙ ПОЛИСАХАРИД Streptococcus pneumoniae И ЕГО ИММУНОГЕННЫЙ КОНЪЮГАТ | |
| NZ770014A (en) | Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof |